MAM
Housing.com sweeps five awards for ‘Look Up’ campaign
MUMBAI: Housing.com bagged five awards at the National Award for Marketing Excellence hosted by CMO Asia. It won in five key categories including ‘Brand Excellence in e-commerce and Internet Business Sector,’ ‘Emerging Brand Award’ and ‘Best New Brand, Product and Service Launch.’
Recognizing the success for Housing.com’s marketing campaign ‘Look Up,’ the company was also awarded ‘Marketing Campaign of the Year’ and ‘Best Use of Social Media.’
National Award for Marketing Excellence recognises organisations and marketers who have achieved extraordinary success for innovative and effective marketing practices. The platform awards marketers who have pushed their brands to measured success through sound and innovative marketing strategies.
Housing.com chief marketing officer Pratik Seal said, “We are thrilled with the accolades and recognition Housing.com’s ambitious ‘Look Up’ campaign has received. The team zealously worked hard to not only push limits in terms of ideation but also executing this mammoth campaign. CMO Asia Awards is known to recognize excellence in marketing; it is a matter of great pride that our first brand campaign has been well received by the marketing fraternity.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
